Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Zill, OA"'
Autor:
Collisson, Eric, Lanman, RB, Mortimer, SA, Zill, OA, Sebisanovic, D, Lopez, R, Blau, S, Collisson, EA, Divers, SG, Hoon, DSB, Scott, E
Publikováno v:
Collisson, Eric; Lanman, RB; Mortimer, SA; Zill, OA; Sebisanovic, D; Lopez, R; et al.(2015). Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2967n1gx
© 2015 Lanman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::52553b1ae3fbbe590e51b4efec292f76
http://www.escholarship.org/uc/item/2967n1gx
http://www.escholarship.org/uc/item/2967n1gx
Autor:
Gurung HR; Genentech, South San Francisco, CA, USA., Heidersbach AJ; Genentech, South San Francisco, CA, USA., Darwish M; Genentech, South San Francisco, CA, USA., Chan PPF; Genentech, South San Francisco, CA, USA., Li J; Genentech, South San Francisco, CA, USA., Beresini M; Genentech, South San Francisco, CA, USA., Zill OA; Genentech, South San Francisco, CA, USA., Wallace A; Genentech, South San Francisco, CA, USA., Tong AJ; Genentech, South San Francisco, CA, USA., Hascall D; Genentech, South San Francisco, CA, USA., Torres E; Genentech, South San Francisco, CA, USA., Chang A; Genentech, South San Francisco, CA, USA., Lou K'; Genentech, South San Francisco, CA, USA., Abdolazimi Y; Genentech, South San Francisco, CA, USA., Hammer C; Genentech, South San Francisco, CA, USA., Xavier-Magalhães A; Genentech, South San Francisco, CA, USA., Marcu A; Genentech, South San Francisco, CA, USA., Vaidya S; Genentech, South San Francisco, CA, USA., Le DD; Genentech, South San Francisco, CA, USA., Akhmetzyanova I; Genentech, South San Francisco, CA, USA., Oh SA; Genentech, South San Francisco, CA, USA., Moore AJ; Adaptive Biotechnologies, Seattle, WA, USA., Uche UN; Adaptive Biotechnologies, Seattle, WA, USA., Laur MB; Adaptive Biotechnologies, Seattle, WA, USA., Notturno RJ; Adaptive Biotechnologies, Seattle, WA, USA., Ebert PJR; Adaptive Biotechnologies, Seattle, WA, USA., Blanchette C; Genentech, South San Francisco, CA, USA. cdblanchette@gmail.com., Haley B; Genentech, South San Francisco, CA, USA. ben.haley@gmail.com., Rose CM; Genentech, South San Francisco, CA, USA. rose.christopher@gene.com.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Jul; Vol. 42 (7), pp. 1107-1117. Date of Electronic Publication: 2023 Oct 19.
Autor:
Johnson RM; Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, CA, USA. johnson.radia@gene.com., Qu X; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA. qu.xueping@gene.com., Lin CF; Real World Data Science Analytics, Genentech, Inc., South San Francisco, CA, USA., Huw LY; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Venkatanarayan A; Discovery Oncology, Genentech, Inc., South San Francisco, CA, USA., Sokol E; Cancer Genomics Research, Foundation Medicine, Inc., Cambridge, MA, USA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Ihuegbu N; Guardant Health, Inc, Redwood City, CA, USA., Zill OA; Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, CA, USA., Kabbarah O; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Wang L; Real World Data Science Analytics, Genentech, Inc., South San Francisco, CA, USA., Bourgon R; Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, CA, USA., de Sousa E Melo F; Discovery Oncology, Genentech, Inc., South San Francisco, CA, USA., Bolen C; Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, CA, USA., Daemen A; Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, CA, USA., Venook AP; University of California, San Francisco, San Francisco, CA, USA., Innocenti F; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lenz HJ; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Bais C; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA. baiscarlos@gmail.com.
Publikováno v:
Nature communications [Nat Commun] 2022 Sep 19; Vol. 13 (1), pp. 5478. Date of Electronic Publication: 2022 Sep 19.
Autor:
Fehlings M; Immunoscape Pte Ltd, Singapore., Kim L; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Guan X; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Yuen K; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Tafazzol A; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Sanjabi S; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Zill OA; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Rishipathak D; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Wallace A; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Nardin A; Immunoscape Pte Ltd, Singapore., Ma S; Immunoscape Pte Ltd, Singapore., Milojkovic A; Immunoscape Pte Ltd, Singapore., Newell EW; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Mariathasan S; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA., Yadav M; Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA yadav.mahesh@gene.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Aug; Vol. 10 (8).
Autor:
Wallace A; Department of Oncology Bioinformatics, Genentech, Inc., San Francisco, California., Porten SP; Department of Urology, University of California, San Francisco, California., Lo AA; Department of Research Pathology, Genentech, Inc., San Francisco, California., Oreper D; Department of Oncology Bioinformatics, Genentech, Inc., San Francisco, California., Lounsbury N; Department of Oncology Bioinformatics, Genentech, Inc., San Francisco, California., Havnar C; Department of Research Pathology, Genentech, Inc., San Francisco, California., Pechuan-Jorge X; Department of Cancer Immunology, Genentech, Inc., San Francisco, California., Zill OA; Department of Oncology Bioinformatics, Genentech, Inc., San Francisco, California., Meng MV; Department of Urology, University of California, San Francisco, California.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2022 Jun 03; Vol. 20 (6), pp. 909-922.
Autor:
Lo AA; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA lo.amy@gene.com oliver@init.bio., Wallace A; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Oreper D; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Lounsbury N; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Havnar C; Department of Research Pathology, Genentech Inc, South San Francisco, California, USA., Pechuan-Jorge X; Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA., Wu TD; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Bourgon R; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA., Jones R; Department of Pathology, Northwestern University, Chicago, Illinois, USA., Krogh K; Department of Pathology, Northwestern University, Chicago, Illinois, USA., Yang GY; Department of Pathology, Northwestern University, Chicago, Illinois, USA., Zill OA; Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA lo.amy@gene.com oliver@init.bio.; Current affiliation, init.bio, Inc, San Mateo, CA, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).
Autor:
Mack PC; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California.; College of Medicine, California Northstate University, Elk Grove, California., Banks KC; Guardant Health, Inc, Redwood City, California., Espenschied CR; Guardant Health, Inc, Redwood City, California., Burich RA; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California., Zill OA; Guardant Health, Inc, Redwood City, California., Lee CE; Guardant Health, Inc, Redwood City, California., Riess JW; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California., Mortimer SA; Guardant Health, Inc, Redwood City, California., Talasaz A; Guardant Health, Inc, Redwood City, California., Lanman RB; Guardant Health, Inc, Redwood City, California., Gandara DR; Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California.
Publikováno v:
Cancer [Cancer] 2020 Jul 15; Vol. 126 (14), pp. 3219-3228. Date of Electronic Publication: 2020 May 04.
Autor:
Odegaard JI; Guardant Health, Redwood City, California. jodegaard@guardanthealth.com., Vincent JJ; Guardant Health, Redwood City, California., Mortimer S; Guardant Health, Redwood City, California., Vowles JV; Guardant Health, Redwood City, California., Ulrich BC; Dana-Farber Cancer Institute, Boston, Massachusetts., Banks KC; Guardant Health, Redwood City, California., Fairclough SR; Guardant Health, Redwood City, California., Zill OA; Guardant Health, Redwood City, California.; Genentech, South San Francisco, California., Sikora M; Guardant Health, Redwood City, California., Mokhtari R; Guardant Health, Redwood City, California., Abdueva D; Guardant Health, Redwood City, California., Nagy RJ; Guardant Health, Redwood City, California., Lee CE; Guardant Health, Redwood City, California., Kiedrowski LA; Guardant Health, Redwood City, California., Paweletz CP; Dana-Farber Cancer Institute, Boston, Massachusetts., Eltoukhy H; Guardant Health, Redwood City, California., Lanman RB; Guardant Health, Redwood City, California., Chudova DI; Guardant Health, Redwood City, California., Talasaz A; Guardant Health, Redwood City, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Aug 01; Vol. 24 (15), pp. 3539-3549. Date of Electronic Publication: 2018 Apr 24.
Autor:
Zill OA; Guardant Health, Inc., Redwood City, California., Banks KC; Guardant Health, Inc., Redwood City, California., Fairclough SR; Guardant Health, Inc., Redwood City, California. sfairclough@guardanthealth.com., Mortimer SA; Guardant Health, Inc., Redwood City, California., Vowles JV; Guardant Health, Inc., Redwood City, California., Mokhtari R; Guardant Health, Inc., Redwood City, California., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, California., Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento, California., Odegaard JI; Guardant Health, Inc., Redwood City, California., Nagy RJ; Guardant Health, Inc., Redwood City, California., Baca AM; Guardant Health, Inc., Redwood City, California., Eltoukhy H; Guardant Health, Inc., Redwood City, California., Chudova DI; Guardant Health, Inc., Redwood City, California., Lanman RB; Guardant Health, Inc., Redwood City, California., Talasaz A; Guardant Health, Inc., Redwood City, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Aug 01; Vol. 24 (15), pp. 3528-3538. Date of Electronic Publication: 2018 May 18.
Autor:
Kim ST; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee WS; Department of Surgery, Gil Medical Center, Gachon University, School of Medicine, Incheon, Korea., Lanman RB; Guardant Health Inc., Redwood City, CA, USA., Mortimer S; Guardant Health Inc., Redwood City, CA, USA., Zill OA; Guardant Health Inc., Redwood City, CA, USA., Kim KM; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea.; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jang KT; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim SH; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park JO; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea., Park YS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lim HY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Eltoukhy H; Guardant Health Inc., Redwood City, CA, USA., Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee WY; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kim HC; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea., Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; The Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea., Talasaz A; Guardant Health Inc., Redwood City, CA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Nov 24; Vol. 6 (37), pp. 40360-9.